Antonio Gualberto
2016
In 2016, Antonio Gualberto earned a total compensation of $762.3K as Head of Development and Chief Medical Officer at Kura Oncology, a 56% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $136,276 |
|---|---|
| Option Awards | $235,215 |
| Salary | $380,100 |
| Other | $10,735 |
| Total | $762,326 |
Gualberto received $380.1K in salary, accounting for 50% of the total pay in 2016.
Gualberto also received $136.3K in non-equity incentive plan, $235.2K in option awards and $10.7K in other compensation.
Rankings
In 2016, Antonio Gualberto's compensation ranked 9,490th out of 14,075 executives tracked by ExecPay. In other words, Gualberto earned more than 32.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,490 out of 14,075 | 33rd |
Division Manufacturing | 3,675 out of 5,486 | 33rd |
Major group Chemicals And Allied Products | 1,272 out of 1,900 | 33rd |
Industry group Drugs | 1,011 out of 1,543 | 35th |
Industry Pharmaceutical Preparations | 794 out of 1,173 | 32nd |
Source: SEC filing on April 26, 2018.
Gualberto's colleagues
We found three more compensation records of executives who worked with Antonio Gualberto at Kura Oncology in 2016.